Trial Summary
What is the purpose of this trial?This trial tests the Medherent platform, a telehealth service that helps people with serious mental illnesses manage their medications and health care. It targets those who often miss their medications and have poor health outcomes. The platform provides remote support to improve their health and reduce hospital visits.
Eligibility Criteria
This trial is for adults aged 18-80 with Serious Mental Illness (SMI) who are prescribed psychiatric medications and receive services from a participating community mental health agency. They must be willing to have the Medherent device in their residence, either as current users or new participants.Inclusion Criteria
I am taking medication for a mental health condition.
Sample 2: Willing or able to authorize to have the Medherent device in your residence
Serious Mental Illness Diagnosis
+4 more
Exclusion Criteria
Unable to have the Medherent device in residence
Participant Groups
The study tests the Medherent medication management platform along with additional telehealth care-coordination services aimed at improving health outcomes for individuals with SMI living in community settings.
3Treatment groups
Experimental Treatment
Active Control
Group I: New MedherentExperimental Treatment1 Intervention
Group using Medherent Device with added interventional components.
Group II: Usual CareActive Control1 Intervention
Usual Care: no intervention elements.
Group III: Existing MedherentActive Control1 Intervention
Group using the Medherent Device with no added intervention components.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of MarylandBaltimore, MD
Loading ...
Who Is Running the Clinical Trial?
University of Maryland, BaltimoreLead Sponsor